Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 233,247,799 papers from all fields of science
Search
Sign In
Create Free Account
bleomycin/dacarbazine/doxorubicin/vinblastine protocol
Known as:
ABVD
, ABVD Regimen
, Adriamycin-Bleomycin-Vinblastine-Dacarbazine Regimen
Expand
A chemotherapy regimen consisting of doxorubicin hydrochloride (Adriamycin), bleomycin, vinblastine and dacarbazine, used alone or in combination…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
7 relations
Broader (1)
ABVD protocol
Adult Hodgkin Lymphoma
Bleomycin
Dacarbazine
Doxorubicin
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2005
Review
2005
Current treatment and immunotherapy of Hodgkin's lymphoma.
B. Klimm
,
R. Schnell
,
V. Diehl
,
A. Engert
Haematologica
2005
Corpus ID: 26969702
The treatment of Hodgkin's lymphoma has changed significantly over the last decades, rendering this entity one of the most…
Expand
2004
2004
Chemotherapy or combined modality treatment: the optimal treatment for Hodgkin's disease.
V. Diehl
Journal of Clinical Oncology
2004
Corpus ID: 28597134
The high cure rates for patients with Hodgkin’s Disease (HD) in all prognostic groups during the last three decades have been…
Expand
Highly Cited
2002
Highly Cited
2002
Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: final results of the…
M. Sieber
,
H. Tesch
,
+23 authors
V. Diehl
Journal of Clinical Oncology
2002
Corpus ID: 26029885
PURPOSE To investigate whether treatment results in intermediate-stage Hodgkin's lymphoma can be improved by rapid application of…
Expand
2000
2000
Thyroid toxicity of treatment for Hodgkin's disease
W. Bethge
,
D. Guggenberger
,
Michael Bamberg
,
L. Kanz
,
Carsten Bokemeyer
Annals of Hematology
2000
Corpus ID: 21511072
Abstract Thyroid disease, especially hypothyroidism, is one of the more frequently encountered late endocrine sequelae of…
Expand
1999
1999
Hodgkin's disease in Turkish children: clinical characteristics and treatment results of 210 patients.
M. Büyükpamukçu
,
L. Atahan
,
M. Çaǧlar
,
T. Kutluk
,
C. Akyüz
,
V. Hazar
Pediatric Hematology & Oncology
1999
Corpus ID: 33617439
Although Hodgkin's disease (HD) is one of the common malignancies in childhood, there is limited information from developing…
Expand
1997
1997
Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease.
D. Longo
,
E. Glatstein
,
+8 authors
V. Devita
Journal of Clinical Oncology
1997
Corpus ID: 25500983
PURPOSE To evaluate the efficacy and toxicity of mechlorethamine, vincristine, procarbazine, and prednisone (MOPP)/doxorubicin…
Expand
1997
1997
Six cycles of ABVD in the treatment of stage I and II Hodgkin's lymphoma: a pilot study.
Antonio Rueda
,
E. Alba
,
N. Ribelles
,
I. Sevilla
,
I. Ruiz
,
J. Miramón
Journal of Clinical Oncology
1997
Corpus ID: 34887799
PURPOSE Chemotherapy is the standard treatment in advanced Hodgkin's lymphoma and a therapeutic alternative for early stages…
Expand
1996
1996
Twelve years experience with high-dose therapy and autologous stem cell transplantation for high-risk Hodgkin's disease patients in first remission after MOPP/ABVD chemotherapy.
A. Carella
,
E. Prencipe
,
+14 authors
M. Federico
Leukemia and Lymphoma
1996
Corpus ID: 30193565
High-dose therapy followed by autografting can cure patients with aggressive Hodgkin's disease (HD) refractory or with early…
Expand
1993
1993
Gonadal function in prepubertal boys following treatment for Hodgkin's disease.
Dhabhar Bn
,
H. Malhotra
,
+4 authors
S. Advani
American Journal Of Pediatric Hematology/Oncology
1993
Corpus ID: 34640293
PURPOSE Gonadal functions were evaluated in 26 male patients with Hodgkin's disease (HD), who were in continuous unmaintained…
Expand
1985
1985
Third-line salvage chemotherapy in Hodgkin's disease.
G. Bonadonna
,
S. Viviani
,
P. Valagussa
,
V. Bonfante
,
A. Santoro
Seminars in Oncology
1985
Corpus ID: 28929570
CEP (CCNU, etoposide, and prednimustine) was tested as third-line chemotherapy in 40 patients resistant to both MOPP and ABVD…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE